L’Agence européenne des médicaments a approuvé ce lundi un vaccin contre le Covid-19 ciblant les sous-variants d’Omicron BA.4 et BA.5, qui échappent plus facilement au système immunitaire que les souches antérieures
Le | Durée : 1:34
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.